Alternatives to Truvada If You Can't Fill Your Prescription

Truvada (emtricitabine/tenofovir disoproxil fumarate) has been a cornerstone of HIV prevention and treatment since 2004. If you've been prescribed it but can't fill your prescription — because of a stockout, insurance hassle, side effect concern, or cost barrier — you have more options today than at any point in history. This guide walks through the FDA-approved alternatives for both PrEP (HIV prevention) and HIV treatment.

Important: Never switch HIV medications without first consulting your prescriber. Changing regimens can affect effectiveness, and some alternatives may not be appropriate for your specific situation.

If You Take Truvada for PrEP (HIV Prevention)

PrEP patients have the most flexibility when it comes to alternatives. There are now four FDA-approved PrEP modalities, each with different dosing schedules and profiles.

Alternative 1: Descovy (Emtricitabine/Tenofovir Alafenamide)

Descovy is the most direct substitute for Truvada as a daily oral PrEP pill. Made by the same manufacturer (Gilead Sciences), it contains emtricitabine (same as Truvada) paired with tenofovir alafenamide (TAF) instead of tenofovir disoproxil fumarate (TDF).

Approved for: PrEP for adults and adolescents at risk through sexual contact (except receptive vaginal sex — Truvada has better data there)

Advantage: Better renal and bone safety profile than TDF-based Truvada — often preferred for patients with kidney concerns or reduced bone density

Disadvantage: Brand-name only in the US as of 2026 (no generic); costs $2,200–$2,900/month without insurance. However, ACA mandate means most insurers must cover it.

Best for: Patients with kidney or bone concerns who need a daily oral pill

Alternative 2: Apretude (Cabotegravir Extended-Release Injectable)

Apretude is a long-acting injectable PrEP option from ViiV Healthcare. After a two-injection loading phase (one month apart), it's given every two months. It belongs to a different drug class — integrase strand transfer inhibitors (INSTIs) — so there's no crossover resistance with TDF-based drugs.

Approved for: PrEP for adults and adolescents at risk through sex (all genders)

Advantage: No daily pill required; proven in clinical trials to be even more effective than daily oral PrEP — showing 66% fewer infections in MSM/transgender women and 89% fewer in cisgender women

Disadvantage: Requires in-office injection every 2 months; ~$4,229/injection without insurance; not available at all pharmacies

Best for: Patients who struggle with daily pill adherence or prefer not to have a daily HIV prevention routine

Alternative 3: Yeztugo / Lenacapavir (Twice-Yearly Injectable)

Yeztugo (lenacapavir) is the newest PrEP option, approved in 2024–2025. It's a capsid inhibitor given as a subcutaneous injection just twice per year — by far the least frequent dosing of any PrEP option. Clinical trials showed it was nearly 100% effective at preventing HIV.

Approved for: PrEP in HIV-negative adults and adolescents weighing at least 35 kg

Advantage: Only two injections per year; near-100% efficacy; no daily medication burden

Disadvantage: Very new; U.S. list price over $14,000 per injection; insurance coverage varies; not widely available at all clinics yet

Best for: Patients who want maximum convenience and the lowest possible medication burden

If You Take Truvada as Part of HIV Treatment

For patients using Truvada as part of an antiretroviral regimen to treat HIV-1 infection, the alternatives are more nuanced and depend on your full regimen, viral load history, resistance profile, and kidney function. Switching ART (antiretroviral therapy) without medical guidance is never appropriate. That said, common regimens that include TDF/FTC can often be transitioned to:

Descovy (FTC/TAF) — as the backbone, if switching from TDF to TAF is appropriate

Biktarvy (bictegravir/FTC/TAF) — a complete single-tablet regimen that includes FTC/TAF plus an integrase inhibitor; highly preferred for initial HIV treatment

Cabenuva (cabotegravir + rilpivirine) — a long-acting injectable HIV treatment given every 1–2 months, for virologically suppressed patients

Quick Comparison: Which Alternative Is Right for You?

Cost is your main concern: Generic Truvada remains the most affordable — as low as $21–$30/month with a coupon

Kidney or bone concerns: Descovy (TAF-based) has a better safety profile for renal function and bone density

Can't remember daily pills: Apretude (every 2 months) or Yeztugo (every 6 months) removes daily burden

PrEP for receptive vaginal sex: Truvada, Apretude, or Yeztugo — Descovy is not approved for this indication

The Most Important Step: Talk to Your Prescriber

Before switching anything, call your prescriber. If the issue is simply that your pharmacy is out of stock, try using medfinder to check which pharmacies near you have Truvada or generic emtricitabine/TDF available — a pharmacy change is much simpler than a medication switch.

See also: How to Find Truvada in Stock Near You.